Company Developes New Way To Diagnose Alzheimer's

Company Developes New Way To Diagnose Alzheimer's

Matthew Meyer, senior proteomics scientist, and Stephanie Knapik, a research associate, work with the Hamilton MICROLAB STAR Liquid Handler at C2N Diagnostics in the Center for Emerging Technologies in St. Louis, on Wednesday, December 2, 2020. C2N Diagnostics has started selling the first blood test to help diagnose Alzheimer's disease. Photo by C2N Diagnostics/UPI